Skip to content
    Crestline Investors logo

    Crestline Investors

    Fort Worth, Texas, United StatesFounded 1997

    Crestline Investors is an institutional alternative investment management firm founded in 1997 and based in Fort Worth, Texas. It specializes in credit and opportunistic investments, including direct lending to lower-middle and middle-market companies, fund liquidity solutions, real estate, and derivative solutions.

    Average disclosed round size is $80.0M (across 7 rounds with reported amounts).

    Find people at Crestline Investors on Goldilocks AI

    Portfolio

    7

    Fund Size

    Top Stage

    Unknown

    Last 12 Mo

    0

    Team

    AM

    Amit Mahajan

    Senior Managing Director, Senior Portfolio Manager

    AP

    Andrey Panna

    Senior Managing Director, Europe

    CS

    Camille Sassman, CPA

    Senior Managing Director, Chief Financial Officer

    JD

    James Delaune

    Senior Managing Director

    JL

    Jeremiah Loeffler, CPA

    Senior Managing Director and COO - Credit

    MA

    Michael Aingorn

    Senior Managing Director, Head of Liquid Credit

    MB

    Michael Blewitt

    Senior Managing Director, Head of Human Resources

    MA

    Mr. Aingorn

    Senior Managing Director, Head of Liquid Credit

    MB

    Mr. Bavin

    Senior Managing Director, Co-Head of Client Partnership Group

    MB

    Mr. Blewitt

    Senior Managing Director, Head of Human Resources

    MC

    Mr. Choy

    Senior Managing Director

    MC

    Mr. Christon

    Senior Managing Director

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    7 investments
    CompanyRoundAmountDate
    Upperline Health logoUpperline HealthUnknown$58.4MJun 2023
    Actifio logoActifioBridge$100MAug 2018
    Vapotherm logoVapothermUnknown$30MJan 2016
    VVapothermIpo$56MJan 2016
    Juno Therapeutics logoJuno TherapeuticsSeries A$176MApr 2014
    AActifio, Inc.Bridge$100MJan 2014
    LLeading PharmaGrowth$40M

    Top Co-Investors

    Last updated: 8 September 2026